GE HealthCare Technologies Inc.

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-15 pm EST			5-day change	1st Jan Change
83.66 ^USD	-0.56%		-3.01%	+7.01%

Jan. 15	GE Healthcare, University of California San Francisco Launching Joint Research Program	MT
Jan. 15	University of California, San Francisco Department of Radiology & Biomedical Imaging and GE HealthCare Technologies Inc. Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology	CI

GE Healthcare Technologies Submits Premarket Application for AI Medical Image Improvement Technology

December 03, 2024 at 08:38 am EST

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about GE HealthCare Technologies Inc.

GE Healthcare, University of California San Francisco Launching Joint Research Program	Jan. 15	MT
University of California, San Francisco Department of Radiology & Biomedical Imaging and GE HealthCare Technologies Inc. Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology	Jan. 15	CI
GE Healthcare Technologies Seeks to Acquire Tuck-In Deals	Jan. 14	CI
GE HealthCare Technologies Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 02:15 PM	Jan. 14
GE Health CEO on Sutter Health Deal, AI in Care Delivery	Jan. 14	MT
GE HealthCare: partnership with the Sutter Health network	Jan. 14	CF
GE Healthcare, Sutter Health Form 7-Year Partnership	Jan. 14	MT
Sutter Health and GE Healthcare Technologies Inc. Enters Strategic Partnership to Benefit Patients, Physicians and Clinicians with Advanced, Ai-Powered Imaging	Jan. 14	CI
GE Healthcare Technologies Shares Rise After Upgrade From Jefferies	Jan. 08	MT
Wall Street's rate cut dreams wane	Jan. 08
Jefferies Upgrades GE Healthcare Technologies to Buy From Hold, Adjusts Price Target to $103 From $95	Jan. 08	MT
GE HEALTHCARE : Jefferies upgrades its buy recommendation	Jan. 08	CF
Analyst recommendations: Adobe, Merck, Take-Two, Palantir, Experian...	Jan. 08
Jefferies Upgrades GE Healthcare Technologies to Buy From Hold, Adjusts Price Target to $103 From $95	Jan. 08	MT
Evercore ISI Cuts Price Target on GE Healthcare Technologies to $98 From $102	Jan. 02	MT
Goldman Sachs Adjusts Price Target on GE Healthcare Technologies to $83 From $88, Maintains Neutral Rating	Dec. 16	MT
GE HealthCare Technologies Inc. Presents at 51st Nasdaq London Investor Conference, Dec-10-2024 11:00 AM	Dec. 10
GE HealthCare: CleaRecon DL submitted for FDA approval	Dec. 03	CF
GE Healthcare Technologies Submits Premarket Application for AI Medical Image Improvement Technology	Dec. 03	MT
GE HealthCare: buyout of remaining 50% stake in Japan's NMP	Dec. 02	CF
GE Healthcare to Acquire Remaining 50% Stake in Nihon Medi-Physics	Dec. 02	MT
GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI	Dec. 01	CI
GE Healthcare Highlights New Solutions Including AI-Enabled Innovations to Drive Precision Care at RSNA 2024	Dec. 01	CI
GE Healthcare Highlights New Solutions Including Ai-Enabled Innovations to Drive Precision Care At Rsna 2024	Dec. 01	CI
GE HealthCare Technologies Inc. agreed to acquire remaining 50% stake in Nihon Medi Physics Co. Ltd from Sumitomo Chemical Company, Limited.	Nov. 30	CI

Chart GE HealthCare Technologies Inc.

Duration

Period

GEHC: Dynamic Chart

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. The Company provides integrated solutions, services, and data analytics. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. The segment also includes the clinical artificial intelligence (AI) software business. Its PCS segment portfolio consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment consists of two business lines: contrast media and molecular imaging.

Employees

51,000

Sector

Advanced Medical Equipment & Technology

Calendar

2025-02-13 - Q4 2024 Earnings Release

More about the company